The Prognostic and Therapeutic Implications of the Chemoresistance Gene BIRC5 in Triple-Negative Breast Cancer is a research paper published in Cancers (2022). On theSindex it has a DataRank of 0. It has been cited 29 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Minority Health and Health Disparities of the National Institutes of Health
Grant: U54 MD007582
National Institute of Minority Health and Health Disparities of the National Institutes of Health
Grant: P20 MD006738
NIMHD NIH HHS
Grant: G12 MD007582
National Institutes of Health
Grant: 5U54MD007582-37
FAMU Center for Health Disparities Research
National Institutes of Health
Grant: 5P20MD006738-02
Administrative Core
FWCI
2.42
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals